In mouse models, certain mutations in T cells synergized with PD-1 blockade to spur uncontrolled growth, resulting in T-cell lymphomas. Jürgen Ruland, a professor of clinical chemistry and pathobiochemistry at the German Technical University of Munich and senior author of the paper reporting the findings, told BioWorld that his team was as surprised as anyone by the results.